These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 5577970

  • 21. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man.
    Breckenridge A, Orme M, Wesseling H, Lewis RJ, Gibbons R.
    Clin Pharmacol Ther; 1974 Apr; 15(4):424-30. PubMed ID: 4821443
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG, Martin PD, Mitchell PD, Lasseter K, Gibson G, Schneck DW.
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
    Guerret M, Francheteau P, Hubert M.
    Pharmacotherapy; 1997 Aug; 17(4):767-73. PubMed ID: 9250555
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA.
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [Abstract] [Full Text] [Related]

  • 32. Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
    Karim A, Tolbert D, Piergies A, Hubbard RC, Harper K, Wallemark CB, Slater M, Geis GS.
    J Clin Pharmacol; 2000 Jun; 40(6):655-63. PubMed ID: 10868317
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG.
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [Abstract] [Full Text] [Related]

  • 36. Decreased sensitivity to warfarin in patients with myxedema.
    Rice AJ, McIntosh TJ, Fouts JR, Brunk SF, Wilson WR.
    Am J Med Sci; 1971 Oct; 262(4):211-5. PubMed ID: 5142577
    [No Abstract] [Full Text] [Related]

  • 37. The effect of diflunisal on the steady state pharmacodynamics and pharmacokinetics of warfarin [proceedings].
    Serlin MJ, Mossman S, Sibeon RG, Breckenridge AM.
    Br J Clin Pharmacol; 1980 Mar; 9(3):287P-288P. PubMed ID: 7362744
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Plasma warfarin concentrations after a massive overdose.
    Hackett LP, Ilett KF, Chester A.
    Med J Aust; 1985 Jun 10; 142(12):642-3. PubMed ID: 4000042
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.